Can We Predict the Sites of the Recurrence of Ovarian Cancer by F-18 FDG PET/CT Depending on CA-125 Level?

TURGUT B., ÇİFTÇİ E., ERTÜRK S. A., Cetin B., Aker H., HASBEK Z.

CURRENT MEDICAL IMAGING REVIEWS, cilt.13, sa.4, ss.431-437, 2017 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Sayı: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.2174/1573405613666170823154759
  • Dergi Adı: CURRENT MEDICAL IMAGING REVIEWS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.431-437
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Objectives: The purpose of the study is predicting the sites of the recurrence with PET/CT by serum CA-125 level and detecting the cut-off value of CA-125 for metastatic ovarian cancer (OC) in comparison with Fluorine-18 FDG PET/CT.